CASI PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
CASI PHARMACEUTICALS, INC. (CASIF) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.70 million as of 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-05-15
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.70M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.34M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $727.00K.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $899.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $1.70M 20-F · filed 2026-05-15 |
| 2024-12-31 | $1.34M 20-F · filed 2025-03-31 |
| 2023-12-31 | $727.00K 20-F · filed 2024-03-28 |
| 2022-12-31 | $899.00K 20-F · filed 2023-04-26 |